期刊文献+

RUNX3抑癌基因真核表达载体的构建以及在膀胱癌T24细胞中的表达 被引量:1

Construction of Eukaryotic Expression Vector pIRES2-EGFP-RUNX3 and Its Expression in Human Bladder Cancer T24 Cells
下载PDF
导出
摘要 【目的】构建真核表达载体pIRES2-EGFP-RUNX3,并在膀胱癌T24细胞株中表达。【方法】RT-PCR从人正常膀胱组织中获取RUNX3基因并测序,将RUNX3基因克隆进pIRES2-EGFP载体,构建真核表达载体pIRES2-EGFP-RUNX3,并进行EcoRⅠ和XhoⅠ酶切验证。脂质体介导下转染人膀胱癌T24细胞,荧光显微镜检测细胞中增强型绿色荧光蛋白(EGFP)的表达。【结果】成功构建了真核表达载体pIRES2-EGFP-RUNX3,用脂质体转染人膀胱癌T24细胞后,在荧光显微镜下观察到带绿色荧光的人膀胱癌T24细胞。【结论】成功构建RUNX3基因的真核表达载体pIRES2-EGFP-RUNX3并在膀胱癌T24细胞中表达,为进一步研究RUNX3与膀胱癌的关系奠定基础。 [Objective] To construct the eukaryotic expression vector pIRES2-EGFP-RUNX3 and to express it in human bladder cancer T24 cells. [Methods] The RUNX3 gene was amplified by RT-PCR from human normal bladder tissue, and was confirmed by DNA sequencing. The eukaryotic expression vector plRES2-EGFP-RUNX3 was constructed by introducing RUNX3 DNA fragment into the pIRES2-EGFP vector, and was eonfirmed by EcoRI and XhoI digestion analysis. The pIRES2-EGFP- RUNX3 was transfected into human bladder cancer T24 cells using lipofectamineTM 2000. The expressed EGFP was observed under fluorescent microscope. [Results] The eukaryotic expression vector pIRES2-EGFP-RUNX3 was successfully construeted and transfected into human bladder cancer T24 cells. The transfected human bladder cancer displaying green fluorescence was observed under fluorescence microscope. [ Conclusions ] The eukaryotic expression vector plRES2-EGFP-RUNX3 was constructed and EGFP could be expressed in human bladder cancer T24 cells. The present study laid the foundation for the further research of the relation of RUNX3 and human bladder cancer.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2009年第A03期64-67,共4页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省科技计划项目(2002C30303)
关键词 RUNX3基因 T24细胞 膀胱肿瘤 RUNX3 T24 cell bladder cancer
  • 相关文献

参考文献10

  • 1Neuhausen A, Florl AR, Grimm MO, et al. DNA methylation alterations in urothelial carcinoma [J]. Ann N Y Acad Sci, 2005,1075(8):993-1001.
  • 2Marsit C J, Karagas MR, Schned A, et al. Carcinogen exposure and epigenetic silencing in bladder cancer [J]. Ann N Y Acad Sci, 2006,1076(9):810-821.
  • 3Yates DR, Rehman I, Abbod MF, et al. Promoter Hypermethylation Identifies Progression Risk in Bladder Cancer [ J ]. Clin Cancer Res, 2007,13 (7) : 2046-2053.
  • 4Greenlee RT, Hi Harmon MB, Murray T, et al. Cancer Statistics [J]. CA Cancer J Clin, 2001,51(9): 15-36.
  • 5Laufer M, Ranalingom S, Schoenberg MP, et al. Intravesical Gemcitabine therapy for superficial transitional cell carcinoma of the bladder phase I and pharmacokinetic study [J]. J Clin Oncol, 2003,21 (4): 697-703.
  • 6Suzuki M, Shigematsu H, Shames DS, et al. DNA methylation-associated inactivation of TGFβ-related genes DRM/Gremlin, RUNX3, and HPPI in human cancers [J]. Sr J Cancer, 2005,93(10) : 1029-1037.
  • 7Kim WJ, Kim E J, Jeong P, et al. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors [ J ]. Cancer Res, 2005,65 (20) : 9347- 9354.
  • 8Li QL, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gatric cancer [ J ]. Cell, 2002, 109 ( 1 ) : 113-124.
  • 9Zaidi SK, Sullivan A J, van Wijnen A J, et al. Integration of RUNX and Smad regularory signals at reanscriptionally active subnuclear sites [J]. Proc Natl Acad Sci USA, 2002,99 (12) : 8048-8053.
  • 10Wagstaff MJD, Lilley CE. Gene transfer using a disabled herpes virus vector containing the EMCV IRES allows multiple gene expression in vitro and in vivo [J]. Gen Ther, 1998,5(11):1566-1570.

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部